New Delhi Metallo-β-Lactamase (NDM-1): An Updates

REFERENCES

• Shakil S, Khan R, Zarrilli R, Khan AU. Aminoglycosides versus bacteria- a description of the action, resistance mechanism, and nosocomial bat-tleground. J Biomed Sci 2008; 15: 5–14.
   PubMed Web of Science ®Google Scholar
• Shakil S, Akram M, Ali SM, Khan AU. Acquisition of extended-spectrum-β-lactamase producing Escherichia colt strains in male and female in-fants admitted to a neonatal intensive care unit: molecular epidemiology and analysis of risk factors. J Med Microbiol 2010a; 59: 948–954.
   PubMed Web of Science ®Google Scholar
• Boucher HW, TalbotBradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: no ESKAPEL An update from the Infectious Dis-eases Society of America. Clin Infect Dis 2009; 48: 1–12.
   PubMed Web of Science ®Google Scholar
• Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 2008; 197: 1079–1081.
   PubMed Web of Science ®Google Scholar
• Bush K. Alarming 3-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr Opin Microbiol 2010; 13: 558–564.
   PubMed Web of Science ®Google Scholar
• Shakil S, Akram M, Khan AU. Tigecycline: a critical update. J Chemother 2008; 20: 411–419.
   PubMed Web of Science ®Google Scholar
• Shakil S, Danishuddin M, Khan AU. Doripenem versus bacteria: an emerging battleground. J Chemother 2009; 21: 482–492.
   PubMed Web of Science ®Google Scholar
• Shakil S, Khan AU. Detection of CTX-M-15-producing and car-bapenem-resistant Acinetobacter baumannii strains from urine from an In-dian hospital. J Chemother 2010; 22: 324–327.
   PubMed Web of Science ®Google Scholar
• Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et al. Characterization of a new metallo-beta-lactamase gene, blaNDmt, and a novel erythromycin esterase gene carried on a unique genetic structure in Kleb-siella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009; 53: 5046–5054.
   PubMed Web of Science ®Google Scholar
• Nordmann P, Poirel L, Toleman MA, Walsh TR. Does broad-spectrum lbetal-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J Antimi-crob Chemother 2011; 66: 689–692.
   PubMed Web of Science ®Google Scholar
• Livermore DM. Has the era of untreatable infections arrived? J Antimicrob Chemother 2009; 64: i29–36.
   PubMed Web of Science ®Google Scholar
• Deshpande P, Rodrigues C, Shetty A, Kapadia F, Hedge A, Soman R. New Delhi Metallo-13 lactamase (NDM-1) in Enterobacteriaceae: Treat-ment options with carbapenems compromised. J Assoc Physicians India 2010; 58: 147–149.
   PubMedGoogle Scholar
• Muir A, Weinbren MJ. New Delhi metallo-beta-lactamase: a cautionary tale. J Hosp Infect 2010; 75: 239–240.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Detection of Enterobacteriaceae Isolates Carrying Metallo-Beta-Lactamase-United States, 2010. MMWR Morb Mortal Wkly Rep 2010; 59: 750.
   Google Scholar
• Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10: 597–602.
   PubMed Web of Science ®Google Scholar
• Tijet N, Alexander DC, Richardson D, Lastovetska O, Low DE, Patel SN, et al. New Delhi metallo-β-lactamase, Ontario, Canada. Emerg Infect Dis 2011; 17: 306–307.
   PubMed Web of Science ®Google Scholar
• Chihara S, Okuzumi K, Yamamoto Y, Oikawa S, Hishinuma A. First case of New Delhi metallo-beta-lactamase 1-producing Escherichia colt in-fection in Japan. Clin Infect Dis 2011; 52: 153–154.
   PubMed Web of Science ®Google Scholar
• Poirel L, Al Maskari Z, Al Rashdi F, Bemabeu S, Nordmann P. NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. J Antimicrob Chemother 2011; 66: 304–306.
   PubMed Web of Science ®Google Scholar
• Sharma VK, Guleria R, Mehta V, Sood N, Singh SN. NDM-1 resist-ance: Fleming's predictions become true. International Journal of Applied Bi-ology and Pharmaceutical Technology 2010; 1: 1244-1251.
   Google Scholar
• Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 2011; 11: 355–362.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhou Z, Jiang Y, Yu Y. Emergence of NDM-1-producing Acinetobacter baumannii in China. J Antimicrob Chemother 2011; 66: 1255–1259.
   PubMed Web of Science ®Google Scholar
• Shahid M. Environmental dissemination of NDM-1: time to act sensi-bly. Lancet Infect Dis 2011; 11: 334–335.
   PubMed Web of Science ®Google Scholar
• Kus JV, Tadros M, Simor A, Low DE, McGeer AJ, Willey BM, et al. New Delhi metallo-β-lactamase-1: local acquisition in Ontario, Canada, and challenges in detection. CMAJ 2011; PMID: 21624908.
   Google Scholar
• Mochon AB, Garner OB, Hindler JA, Krogstad P, Ward KW, Lewin-ski MA, et al. New Delhi Metallo-lbeta)-lactamase (NDM-1) producing Kleb-siella pneumoniae: a case report and laboratory detection strategies. J Clin Microbiol 2011; PMID: 21325558.
   Google Scholar
• Roy S, Viswanathan R, Singh AK, Das P, Basu S. Sepsis in neonates due to imipenem-resistant Klebsiella pneumoniae producing NDM-1 in India. J Antimicrob Chemother 2011; PMID: 21393155.
   Google Scholar
• Mulvey MR, Grant JM, Plewes K, Roscoe D, Boyd DA. New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia colt, Canada. Emerg Infect Dis 2011; 17: 103–106.
   PubMed Web of Science ®Google Scholar
• Poirel L, Schrenzel J, Cherkaoui A, Bernabeu S, Renzi G, Nordmann P. Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland. J Antimicrob Chemother 2011; PMID: 21628303.
   Google Scholar
• Jovcic B, Lepsanovic Z, Suljagic V, Rackov G, Begovic J, Topisirovic L, et al. Emergence of NDM-1 metallo-beta-lactamase in Pseudomonas aeruginosa clinical isolates from Serbia. Antimicrob Agents Chemother. 2011; PMID: 21646490.
   Google Scholar
• Yamamoto T, Takano T, Iwao Y, Hishinuma A. Emergence of NDM-1-positive capsulated Escherichia coli with high resistance to serum killing in Japan. J Infect Chemother. 2011; 17: 435–439.
   PubMed Web of Science ®Google Scholar
• Poirel L, Fortineau N, Nordmann P. International Transfer of NDM-1-Producing Klebsiella pneumoniae from Iraq to France. Antimicrob Agents Chemother 2011; 55: 1821–1822.
   PubMed Web of Science ®Google Scholar
• Peirano G, Schreckenberger PC, Pitout JD. Characteristics of NDM-1-Producing Escherichia colt Isolates That Belong to the Successful and Vir-ulent Clone 5T131. Antimicrob Agents Chemother. 2011; 55: 2986–2988.
   PubMed Web of Science ®Google Scholar
• Bogaerts P, Bouchahrouf W, de Castro RR, Deplano A, Berhin C, Piérard D, et al. Emergence of NDM-1-Producing Enterobacteriaceae in Belgium. Antimicrob Agents Chemother. 2011 Jun; 55 (6): 3036–8.
   PubMed Web of Science ®Google Scholar
• Kaase M, Nordmann P, Wichelhaus TA, Gatermann SG, Bonnin RA, Poirel L. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother. 2011; 66: 1260–1262.
   PubMed Web of Science ®Google Scholar
• Nordmann P, Poirel L, Caner A, Toleman MA, Walsh 'TR. How to de-tect NDM-1 producers? J Clin Microbiol 2011; 49: 718–721.
   PubMed Web of Science ®Google Scholar
• Krüttgen A, Razavi S, Imähl M, Ritter K. Real-time PCR assay and a synthetic positive control for the rapid and sensitive detection of the emerg-ing resistance gene New Delhi Metallo-β-lactamase-1 (bla (NDM-1)). Med Mi-crobiol Immunol 2011; PMID: 21350860.
   Google Scholar
• Diene SM, Bruder N, Raoult D, Rolain JM. Real-time PCR assay al-lows detection of the New Delhi metallo-β-lactamase (NDM-1)-encoding gene in France. Int J Antimicrob Agents. 2011; 37: 544–546.
   PubMed Web of Science ®Google Scholar
• Naas T, Cuzon G, Bogaerts P, Glupczynski Y, Nordmann P. Evalua-tion of a DNA microarray (Check-MDR CT102) for the rapid detection of TEM, S1-IV and CTX-M extended-spectrum-β-lactamases (ESBLs), and of KPC, OXA-48, VIM, IMP, and NDM-1 carbapenemases. J Clin Micro-biol 2011; PMID: 21325547.
   Google Scholar
• Woodford N. NDM producers in the UK as the example of rapid in-vasion of a European country. [recorded session] Presented at the 21't Eu-ropean Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Milan, Italy, May 7-10, 2011. Avaialable at (http://www.escmid.org/es-cmid_br_library/online_lecture_library/eccmid/21st_eccmid27th_icc_2011_ milan/recorded_sessions_2011/); accessed on June 15, 2011.
   Google Scholar
• Wang JF, Chou KC. Insights from modeling the 3D structure of New Delhi metallo-β-lactamse and its binding interactions with antibiotic drugs. PLoS ONE 6 (4): e18414. doi:10.1371/journal.pone.0018414.
   Google Scholar
• Zhang HM, Hao Q. Crystal structure of NDM-1 reveals a common {beta}-lactam hydrolysis mechanism. FASEB J 2011; PMID: 21507902.
   Google Scholar
• Docquier JD, Stachyra T, Benvenuti M et al. High resolution crystal structure of CTX M 15 in complex with the new 3-lactamase inhibitor NXL104 [poster] Presented at the 49th Interscience Conference on An-timicrobial Agents and Chemotherapy (ICAAC), San Francisco, California, USA, Sep 12-15, 2009.
   Google Scholar
• Livermore DM, Mushtaq S, Warner M, Zhang J, Maharjan S, Doumith M, et al. Activities of NXL104 Combinations with Ceftazidime and Aztre-onam against Carbapenemase-Producing Enterobacteriaceae. Antimicrob Agents Chemother 2011; 55: 390–394.
   PubMed Web of Science ®Google Scholar
• Shakil S, Khan AU. Interaction of 2009 CTX-M variants with drugs and inhibitors: a molecular modelling and docking study. J Proteomics Bioin-formatics 2010; 3: 130–134.
   Google Scholar
• Shakil S, Khan AU. Infected foot ulcers in male and female diabetic patients: a clinico-bioinformative study. Ann Clin Microbiol Antimicrob 2010; 9: 2.
   PubMed Web of Science ®Google Scholar
• Bindayna K, Khanfar HS, Senok AC, Botta GA. Predominance of CTX-M genotype among extended spectrum beta lactamase isolates in a ter-tiary hospital in Saudi Arabia. Saudi Med J 2010; 30: 859–863.
   Google Scholar